AC Immune ACIU
NASDAQ ACIU
$2.47 -0.02 (-0.80%)
At close: Oct 21, 2026 · 4:00 PM EDT

AC Immune (ACIU) Long-Term Deferred Tax (2019 - 2026)

Updated

Analysis

AC Immune (ACIU) Long-Term Deferred Tax (2019 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 AC Immune 249.36 Mn -189.04 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.60 Mn
Sep 30, 2024 19,036.29
Jun 30, 2024 50,082.36
Sep 30, 2021 131,656.41
Jun 30, 2021 377,891.19
Mar 31, 2021 615,913.90
Sep 30, 2020 1.17 Mn
Jun 30, 2020 1.48 Mn
Mar 31, 2020 2.55 Mn
Sep 30, 2019 4.74 Mn
Jun 30, 2019 4.04 Mn
Mar 31, 2019 3.56 Mn
API Access

AC Immune Long-Term Deferred Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=ACIU&period=max&api_key=YOUR_API_KEY